Editorial Board
Haibo Xu
Department of Pharmacology, State Key Laboratory for Research and Development of Chinese Materia Medica, Chengd University of Traditional Chinese Medicine · China
Editorial leadership for International Journal of Complementary Medicine ISSN 3070-3360
Research interests
- Pathogenesis Of Gastrointestinal Cancer
- Hepatitis
- Hypertension
- And The Therapeutic Intervention In These Diseases With Traditional Chinese Medicine
- Along With The Delineation Of The Underlying Mechanisms For Chinese Herbal Effects
Biography
- Dr. Haibo Xu is a professor in the department of pharmacology, school of pharmacy, at the Chengdu University of Traditional Chinese Medicine (TCM), Sichuan, China.
- He got a bachelor's degree in medicine at the Southwest Medical University in China in 1997, a master's degree in pharmacology at the Guangzhou University of TCM in 2000, and a PhD in molecular pharmacology at the Guangzhou University of TCM in 2003, followed by his 6-month lectureship in the institute of gastroenterology, Guangzhou University of TCM, Guangdong, China.
- From March 2004 to February 2007, Dr. Xu was a postdoctoral research fellow in cancer biology in the department of surgery, centre for cancer research and cell biology, Queen’s University Belfast, UK, followed by another over 3-year research on hypertension in the school of physiology and pharmacology in the University of Bristol, UK.
- Dr. Xu has been holding several research grants as a principle investigator in China, with 40 published papers and 6 oral presentations in international conferences.
- He was awarded the European Investigators’ Travel Grant by the 19th European meeting on hypertension in Milan, organized by the European Society of Hypertension in 2009.
- He also received 4 travel grants from British Heart Foundation, Physiological Society of UK and the Cancer Recognised Research Group of Northen Ireland.
Selected publications
- Ursolic Acid Suppresses Colorectal Cancer by Down-Regulation of Wnt/β-Catenin Signaling Pathway Activity 2023 cited 77×
- Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis 2024 cited 67×
- Ursolic acid inhibits the activation of smoothened‐independent non‐canonical hedgehog pathway in colorectal cancer by suppressing AKT signaling cascade 2022 cited 14×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering IJCO for your work?
This journal is guided by Haibo Xu (Department of Pharmacology, State Key Laboratory for Research and Development of Chinese Materia Medica, Chengd University of Traditional Chinese Medicine) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.